Global Cochlear Implants Market Grow at A CAGR Of 13.88% during the Period 2016-2020

Date: 2016-09-12

Owe to the rapid increase in aging population and the recent rise in the prevalence of acquired hearing loss will drive the prospects for growth in Cochlear Implants market, estimated Cochlear Implants market grow at a CAGR of 13.88% during the period 2016-2020.

In the North America, medical costs of Cochlear Implants run from US$47,000 to US$130,000; this includes evaluation, the surgery itself, and device.

A cochlear implant (CI) is a surgically implanted electronic device that provides a sense of sound to a person who is profoundly deaf or severely hard of hearing in both ears. Cochlear implants bypass the normal hearing process; they have a microphone and some electronics that reside outside the skin, generally behind the ear, which transmits a signal to an array of electrodes placed in the cochlea, which stimulate the cochlear nerve.

A 2013 study on efficacy of cochlear implants in children showed that the majority of deaf children who received cochlear implants before 18 months of age had language skills similar to their hearing peers. Younger age of implantation had a positive correlation to better spoken language skills.

A 2015 review, examining whether CI implantation to treat people with bilateral hearing loss had any effect on tinnitus, found the quality of evidence to be poor, and the results variable: overall total tinnitus suppression rates varied from 8% to 45% of people who received CI; decrease of tinnitus was seen in 25% to 72%, of people; for 0% to 36% of the people there was no change; increase of tinnitus occurred in between 0% to 25% of patients; and in between 0 – 10% of cases, people who didn’t have tinnitus before the procedure, got it.

Manufacturers around the world
Currently, the three cochlear implant devices approved for use in the U.S. were manufactured by Cochlear Limited (Australia), Advanced Bionics (USA, a division of Sonova) and MED-EL (Austria). In Europe, Africa, Asia, South America, and Canada, an additional device manufactured by Neurelec (France, a division of William Demant) was available. A device made by Nurotron (China) was also available in some parts of the world.

Read Full Report:

Joanna | Executive – International Business and partner Relations
E-mail: | Tel: 001-510-400-8520


Contact With Us
Join templatemonster at google+
Customized Research
Request Sample